2016
DOI: 10.1165/rcmb.2015-0045oc
|View full text |Cite
|
Sign up to set email alerts
|

Acceleration of Lung Regeneration by Platelet-Rich Plasma Extract through the Low-Density Lipoprotein Receptor–Related Protein 5–Tie2 Pathway

Abstract: Angiogenesis, the growth of new blood vessels, plays a key role in organ development, homeostasis, and regeneration. The cooperation of multiple angiogenic factors, rather than a single factor, is required for physiological angiogenesis. Recently, we have reported that soluble platelet-rich plasma (PRP) extract, which contains abundant angiopoietin-1 and multiple other angiogenic factors, stimulates angiogenesis and maintains vascular integrity in vitro and in vivo. In this report, we have demonstrated that mo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
67
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 27 publications
(72 citation statements)
references
References 49 publications
(32 reference statements)
4
67
0
1
Order By: Relevance
“…This important result demonstrates that ASA alone inhibits some components of acute lung inflammation in humans and human tissues under some conditions, but it may not be sufficient to alter the natural history of ARDS. An additional possibility regarding the negative LIPS-A outcome is that platelets have barrier-protective activities (Figure 4) and alveolar reparative potential in the injured lung (14,(188)(189)(190) that might be blunted by antiplatelet agents such as ASA (12). As a corollary, evidence that platelets have defensive activities against pathogens continues to evolve (7,15,26,28,191); these functions could also be reduced by inhibitory drugs.…”
Section: Antiplatelet Agents In Prevention and Therapy Of Ardsmentioning
confidence: 99%
“…This important result demonstrates that ASA alone inhibits some components of acute lung inflammation in humans and human tissues under some conditions, but it may not be sufficient to alter the natural history of ARDS. An additional possibility regarding the negative LIPS-A outcome is that platelets have barrier-protective activities (Figure 4) and alveolar reparative potential in the injured lung (14,(188)(189)(190) that might be blunted by antiplatelet agents such as ASA (12). As a corollary, evidence that platelets have defensive activities against pathogens continues to evolve (7,15,26,28,191); these functions could also be reduced by inhibitory drugs.…”
Section: Antiplatelet Agents In Prevention and Therapy Of Ardsmentioning
confidence: 99%
“…Mammoto et al (2016) [67] reported that PRP accelerates lung regeneration since it contains abundant angiopoietin-1 which stimulates new blood vessels formation, maintains vascular integrity in vitro and in vivo and increases phosphorylation levels of lowdensity lipoprotein receptor-related protein 5 (LRP5) and thus activates angiogenic factor receptor Tie2 in endothelial cells (ECs) and accelerates endothelial cell sprouting. What's more, PRP promotes Achilles tendon healing [68] epithelialization and angiogenesis of splitthickness skin graft donor sites [69] .…”
Section: Additionally Wright Carpenter Et Al(2004)mentioning
confidence: 99%
“…We and other groups have shown that the Wnt ligand co-receptor, low-density lipoprotein receptor-related protein 5 (LRP5) controls various angiogenic pathways (e.g., angiopoietins (Angs)-Tie2 [15,17], VEGF-VEGFR2 [27,28], neuropilin (NRP2) [29]), and stimulates retinal [27,3032] and lung vascular development in neonatal mice [14–17]. LRP5 also mediates compensatory lung growth after PNX in young adult mice through Ang-Tie2 signaling [33]. Thus, LRP5 signaling may be the key control point for the impairment of vascular and alveolar morphogenesis in the aged lung.…”
Section: Introductionmentioning
confidence: 99%